|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Jan―24 |
Association of common variant rs9934336 of SLC5A2 (SGLT2) gene with SARS-CoV-2 infection and mortality |
Anamika Das, Gunanidhi Dhangadamajhi |
2 |
[GO] |
2023―Dec―11 |
Evaluation of therapeutic potentials of some bioactive compounds in selected African plants targeting main protease (Mpro) in SARS-CoV-2: a molecular docking study |
Ishola Abeeb Akinwumi, Barakat Olamide Ishola, Oluwatosin Maryam Adeyemo, Adefolarin Phebean Owojuyigbe |
3 |
[GO] |
2023―Oct―30 |
The role of miRNA20a and miRNA320 in Iraqi patients with COVID-19: a case-control study |
Reema Mohammed Abed, Hadeel Waleed Abdulmalek, Laith Ahmad Yaaqoob |
4 |
[GO] |
2023―May―29 |
Association between leukocyte telomere length and COVID-19 severity |
Ata Mahmoodpoor, Sarvin Sanaie, Maqsoud Eskandari, Nazila Behrouzi, Majid Taghizadeh, Faranak Roudbari, et al. (+3) Babak Emamalizadeh, Nasim Sohrabifar, Somayeh Kazeminasab |
5 |
[GO] |
2023―Jan―26 |
The role of HLA genotypes in understanding the pathogenesis of severe COVID-19 |
Fatemeh Arab, Samaneh Mollazadeh, Farnaz Ghayourbabaei, Meysam Moghbeli, Ehsan Saburi |
6 |
[GO] |
2023―Jan―22 |
HLA alleles associated with COVID-19 susceptibility and severity in different populations: a systematic review |
Meryem Fakhkhari, Hayat Caidi, Khalid Sadki |
7 |
[GO] |
2023―Jan―09 |
Genetic diversity of Mycobacterium tuberculosis isolates from northwest of Iran during COVID-19 era |
Peyvand Kashi, Farzaneh Pakdel, Mohammad Hossein Soroush Barhaghi, Mohammad Ahangarzadeh Rezaee, Sepehr Taghizadeh, Javid Sadeghi, et al. (+5) Mehdi Yousefi, Reza Ghotaslou, Mohammad Asgharzadeh, Pourya Gholizadeh, Hossein Samadi Kafil |
8 |
[GO] |
2022―Oct―20 |
A systems biology approach for investigating significantly expressed genes among COVID-19, hepatocellular carcinoma, and chronic hepatitis B |
Babak Sokouti |
9 |
[GO] |
2022―Oct―01 |
Implication of single nucleotide polymorphisms in Interleukin-10 gene (rs1800896 and rs1800872) with severity of COVID-19 |
Saliha Rizvi, S. Mohd.Shiraz Rizvi, Syed Tasleem Raza, Mohd. Abbas, Kaynat Fatima, Zeashan H. Zaidi, Farzana Mahdi |
10 |
[GO] |
2022―Sep―23 |
Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Engy Elekhnawy, Gaber El-Saber Batiha |
11 |
[GO] |
2022―Sep―15 |
Lysosomal storage diseases in the era of COVID-19: a report of an Egyptian case of alpha-fucosidosis and a summary of the lysosomal storage diseases-COVID-19 relationship |
Heba Saed El-Amawy, Heba Dawoud |
12 |
[GO] |
2022―Aug―23 |
Association between single nucleotide polymorphism of human angiotensin-converting enzyme 2 gene locus and clinical severity of COVID-19 |
Shaimaa A. Elbadri, Nermeen M. A. Abdallah, Mona El-Shokry, Amr Gaber, Mahmoud Kh. Elsayed |
13 |
[GO] |
2022―Aug―03 |
Characterization of the expressed RNA variants from young patients with critical and non-critical SARS-CoV-2 infection |
Javan Okendo |
14 |
[GO] |
2022―Jun―19 |
Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication |
Amir Pouremamali, Abouzar Babaei, Somayeh Shatizadeh Malekshahi, Ardeshir Abbasi, Nastaran Rafiee |
15 |
[GO] |
2022―May―28 |
The role of angiotensin-converting enzyme 2 (ACE2) genetic variations in COVID-19 infection: a literature review |
Manal S. Fawzy, Hend Ashour, Aya Allah Ashraf Shafie, Nesrine Ben Hadj Dahman, Abdelhamid M. Fares, Sarah Antar, et al. (+2) Ahmed S. Elnoby, Fatma Mohamed Fouad |
16 |
[GO] |
2022―Apr―28 |
Investigating expressed RNA variants that are related to disease severity in SARS-CoV-2-infected patients with mild-to-severe disease |
Javan Okendo, David Okanda |
17 |
[GO] |
2022―Mar―25 |
The potential application of probiotics for the prevention and treatment of COVID-19 |
Engy Elekhnawy, Walaa A. Negm |
18 |
[GO] |
2022―Mar―16 |
Influence of COVID-19 pandemic lockdown on a sample of Egyptian children with Down syndrome |
Nagwa A. Meguid, Neveen Hassan Nashaat, Hanaa Reyad Abdallah, Maha Hemimi, Ahmed Elnahry, Hazem Mohamed El-Hariri, Amal Elsaeid |
19 |
[GO] |
2022―Mar―07 |
The role of tumor necrosis factor alpha - 308A > G polymorphism on the clinical states of SARS-CoV-2 infection |
Francisco Sotomayor-Lugo, Claudia Alemañy-Díaz Perera, Hilda Roblejo-Balbuena, Yaíma Zúñiga-Rosales, Giselle Monzón-Benítez, Beatriz Suárez-Besil, et al. (+8) María de los Ángeles González-Torres, Bárbara Torres-Rives, Yudelmis Álvarez-Gavilán, Maidalys Bravo-Ramírez, Nayade Pereira-Roche, Yudelkis Benítez-Cordero, Luis Carlos Silva-Ayçaguer, Beatriz Marcheco-Teruel |
20 |
[GO] |
2022―Mar―04 |
SARS-CoV-2 origin, myths and diagnostic technology developments |
Josephine Wambani, Patrick Okoth |
21 |
[GO] |
2022―Feb―04 |
Design of a multi-epitope-based peptide vaccine against the S and N proteins of SARS-COV-2 using immunoinformatics approach |
Arian Karimi Rouzbahani, Farnaz Kheirandish, Seyedeh Zeinab Hosseini |
22 |
[GO] |
2022―Jan―30 |
Coronavirus-linked pregnancy complications: a comparative study |
Miapeh Kous Gonlepa, Olayemi Hafeez Rufai, Chidinmma Grace Ofuonye, Lapologang Sebaka |
23 |
[GO] |
2022―Jan―21 |
Morbidity and mortality of COVID-19 negatively associated with the frequency of consanguineous marriages, an ecologic study |
Mostafa Saadat |
24 |
[GO] |
2022―Jan―20 |
ABO blood grouping and COVID-19: a hospital-based study in Eastern India |
Birasen Behera, Bidyutprava Rout, Subrat Kumar Kar, Debasish Sahoo, Kundan Kumar Sahu, Sarita Otta |
25 |
[GO] |
2022―Jan―10 |
Oral cavity infection by the SARS-CoV-2: emphasizing the essence of masking and peptide therapeutics |
Glory Omini Ibiang, Joseph Malachi, Mercy Omini Ibiang, Daniel Kenechi Chukwudi, Olanrewaju Ayodeji Durojaye |
26 |
[GO] |
2021―Nov―30 |
TaqI polymorphism of the VDR gene: aspects related to the clinical behavior of COVID-19 in Cuban patients |
Estela Morales Peralta, Yaíma Zúñiga Rosales, Teresa Collazo Mesa, Elvia Nelmi Santos González, Yadira Hernández Pérez, María de los Ángeles González Torres, et al. (+2) Hilda Roblejo Balbuena, Beatriz Marcheco Teruel |
27 |
[GO] |
2021―Nov―26 |
Coronavirus disease 19 and risk of hyperglycemia among Iraqi patients |
Ali H. Ad’hiah, Noor T. Al-Bayatee, Aeshah A. Ahmed |
28 |
[GO] |
2021―May―07 |
Characterization of the SARS-CoV-2 coronavirus X4-like accessory protein |
Olanrewaju Ayodeji Durojaye, Nkwachukwu Oziamara Okoro, Arome Solomon Odiba |
29 |
[GO] |
2021―Jan―05 |
Susceptibility to the novel coronavirus disease (COVID-19) is associated with ABO and Rh blood groups: a case-control study from Afghanistan |
Khyber Saify, Mohammad Sarwar Alborz, Mostafa Saadat |
30 |
[GO] |
2020―Dec―31 |
Understanding the genetic determinant of severity in viral diseases: a case of SARS-Cov-2 infection |
Babayemi Olawale Oladejo, Covenant Femi Adeboboye, Tinuola Tokunbo Adebolu |
31 |
[GO] |
2020―Dec―17 |
Association between ABO blood groups and susceptibility to COVID-19: profile of age and gender in Iraqi patients |
Ali H. Ad’hiah, Maha H. Abdullah, Mustafa Y. Alsudani, Rasool M. S. Shnawa, Ali J. R. Al-Sa’ady, Risala H. Allami, et al. (+3) Khawla I. Misha’al, Iftikhar A. Jassim, Estabraq A. Taqi |
32 |
[GO] |
2020―Dec―16 |
Low iron mitigates viral survival: insights from evolution, genetics, and pandemics-a review of current hypothesis |
Rahma Menshawey, Esraa Menshawey, Ayman H. K. Alserr, Antoine Fakhry Abdelmassih |
33 |
[GO] |
2020―Dec―09 |
Contributory role of SARS-CoV-2 genomic variations and life expectancy in COVID-19 transmission and low fatality rate in Africa |
Olabode E. Omotoso |
34 |
[GO] |
2020―Nov―25 |
An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor |
Olanrewaju Ayodeji Durojaye, Divine Mensah Sedzro, Talifhani Mushiana, Henrietta Onyinye Uzoeto, Samuel Cosmas, Judith Nnedimkpa Ajima, Glory Omini Ibiang |
35 |
[GO] |
2020―Oct―01 |
Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study |
Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Henrietta Onyinye Uzoeto, Samuel Cosmas, Victor Malachy Udowo, Abayomi Gaius Osotuyi, et al. (+2) Glory Omini Ibiang, Miapeh Kous Gonlepa |
36 |
[GO] |
2020―Sep―30 |
The morbidity and mortality of COVID-19 are correlated with the Ile105Val glutathione S-transferase P1 polymorphism |
Mostafa Saadat |
37 |
[GO] |
2020―Sep―20 |
COVID-19 susceptibility: potential of ACE2 polymorphisms |
Mayank Chaudhary |
38 |
[GO] |
2020―Sep―10 |
Evaluating of the association between ABO blood groups and coronavirus disease 2019 (COVID-19) in Iraqi patients |
Ali H. Ad’hiah, Risala H. Allami, Raghdan H. Mohsin, Maha H. Abdullah, Ali J. R. AL-Sa’ady, Mustafa Y. Alsudani |
39 |
[GO] |
2020―Jul―26 |
An in silico epitope-based peptide vaccine design against the 2019-nCoV |
Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Samuel Cosmas, Glory Omini Ibiang, Mercy Omini Ibiang |